UK B.1.1.7 (Alpha) variant exhibits increased respiratory replication and shedding in nonhuman primates

Emerg Microbes Infect. 2021 Dec;10(1):2173-2182. doi: 10.1080/22221751.2021.1997074.

Abstract

The continuing emergence of SARS-CoV-2 variants calls for regular assessment to identify differences in viral replication, shedding and associated disease. In this study, we compared African green monkeys infected intranasally with either the UK B.1.1.7 (Alpha) variant or its contemporary D614G progenitor. Both variants caused mild respiratory disease with no significant differences in clinical presentation. Significantly higher levels of viral RNA and infectious virus were found in upper and lower respiratory tract samples and tissues from B.1.1.7 infected animals. Interestingly, D614G infected animals showed significantly higher levels of viral RNA and infectious virus in rectal swabs and gastrointestinal tissues. Our results indicate that B.1.1.7 infection in African green monkeys is associated with increased respiratory replication and shedding but no disease enhancement similar to human B.1.1.7 cases.

Keywords: African green monkey; SARS-CoV-2; transmission; variants of concern (VOC); virulence.

MeSH terms

  • Administration, Intranasal
  • Animals
  • COVID-19 / epidemiology
  • COVID-19 / virology*
  • Chlorocebus aethiops / virology*
  • Gastrointestinal Tract / virology
  • Host Specificity
  • Polymorphism, Single Nucleotide
  • RNA, Viral / isolation & purification
  • Random Allocation
  • Rectum / virology
  • Respiratory System / virology*
  • United Kingdom / epidemiology
  • Vero Cells
  • Viral Load
  • Virus Replication*
  • Virus Shedding*

Substances

  • RNA, Viral

Grants and funding

This work was supported by Division of Intramural Research, National Institute of Allergy and Infectious Diseases: [COVID].